Remote Jobs at Kyverna Therapeutics

Logo of Kyverna Therapeutics

Kyverna Therapeutics

51 - 200 employees

Founded 2019

🧬 Biotechnology

💊 Pharmaceuticals

🔬 Science

💰 $85M Series B on 2022-01

Biotechnology • Pharmaceuticals • Science

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.

💼 Job Title
🇺🇸 United States – Remote USA
💵 Minimum Salary
⚪️ Experience
Is on LinkedIn?
11 total jobs
1 new jobs this week ⚡️
0% are NOT on LinkedIn 🚫
Looking for a remote job? Search our job board for 100,000+ remote jobs
Search Remote Jobs